DONALD A DURECKI MD
Prescription History 1982648721
Obstetrics & Gynecology in Warsaw, IN

Active since June 15, 2006
64.2/100
CMS Quality Rating
1275 PROVIDENT DR, WARSAW, IN 46580(574) 269-4026(574) 269-7444 Get Directions

NPPES record last updated: January 31, 2018. Verified against the NPPES registry weekly; last sync: July 19, 2026.

Record update history: Jun 17, 2016, Mar 15, 2016 (2 updates tracked since 2016).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DONALD A DURECKI MD, an active Obstetrics & Gynecology specialist practicing in Warsaw, IN. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 17 documented patient claims. Among these therapy options, the most frequently utilized medication is Estradiol, which accounts for 17 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
17
Total Claims
43
30-Day Fills
Estradiol
Most Prescribed · 17 claims
View details
1 medication · 2023 Medicare Part D
Medicare Part D medications prescribed by DONALD A DURECKI MD in 2023, with claim volumes, costs, and IN state comparisons
Medication Claims 30-Day Fills Days Supply Cost / Claim Utilization vs IN Avg
Estradiol1742.81,284$24.04▼ below IN avg Below Avg.

Utilization: claims vs the average IN prescriber

This provider
17
IN average
28.0

Averages are among IN prescribers of this medication. Utilization reflects practice size as well as clinical preference.

Cost per claim: this provider vs the IN average

This provider
$24.04
IN average
$55.88

This provider's average cost per claim is below the IN average for this medication.

42.8
30-Day Fills
1,284
Days Supply

About Estradiol: This medication is a female hormone (estrogen). Show more ▾

It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.

No medications match the current filters.
Above Avg. Typical Below Avg.= utilization vs the average IN prescriber of the same drug; volume reflects practice size as well as clinical preference.Green cost= below the IN average cost per claim.

About this data. The prescription history for DONALD A DURECKI MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Obstetrics & Gynecology prescribing approach at this Warsaw, IN practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among IN prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.